Fortune September 30, 2024
The nationwide summer surge in COVID infections prompted the U.S. Food and Drug Administration (FDA) to approve and authorize for emergency use updated vaccines earlier than expected. Yet now that three 2024–25 coronavirus shots are widely available, only less than half of Americans most at risk of severe infection plan to get immunized.
That’s according to the National Poll on Healthy Aging, a project of the University of Michigan Institute for Healthcare Policy and Innovation. In the weighted survey of nearly 3,500 U.S. adults aged 50 and older, 45% said they were very or somewhat likely to get the new vaccine. About 47% said they were very or somewhat unlikely to do so, and 8% were unsure.
Even if you’re...